作者: José Alvarez-Sabín , Carlos A. Molina , Joan Montaner , Juan F. Arenillas , Rafael Huertas
DOI: 10.1161/01.STR.0000068406.30514.31
关键词: Modified Rankin Scale 、 Stroke 、 Thrombolysis 、 Surgery 、 Middle cerebral artery 、 Internal medicine 、 Tissue plasminogen activator 、 Cardiology 、 Transcranial Doppler 、 Infarction 、 T-plasminogen activator 、 Medicine
摘要: Background and Purpose—We sought to investigate the impact of hyperglycemia before reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen activator (tPA). Methods—Of 268 consecutive patients with a nonlacunar middle cerebral artery (MCA) stroke evaluated at< 3 hours after onset, 73 (27.2%) received intravenous tPA. Serum glucose was determined at baseline before tPA administration. Hyperglycemia was defined as a glucose level> 140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) …